Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Annals of hematology 44 (1982), S. 271-274 
    ISSN: 1432-0584
    Keywords: ALL ; Chromosome analysis ; Translocation t (4; 11)
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Two patients with acute lymphocytic leukemia are described in whom G- and R-banding analysis revealed in bone marrow cells a translocation t (4; 11) (q21; q23). The clinical data are compared to the other four cases with t (4; 11) reported so far in the literature. The anomaly seems to be characteristic for ALL. In addition it appears to be associated with a very high number of circumlating blasts and other poor prognostic factors.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-0584
    Keywords: Key words Hodgkin's disease ; Non-Hodgkin's lymphoma ; Salvage therapy ; ASHAP protocol ; High-dose therapy ; Autologous stem cell transplantation
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Background: This study was performed to examine the efficacy and toxicity of the combination of adriamycin (ADR), methylprednisolone (solumedrol), cytarabine (Ara-C), and cisplatin (CDDP) in patients with recurrent and refractory malignant lymphomas. Patients and methods: Sixty-five patients with Hodgkin's disease (HD) (n=14) or non-Hodgkin's lymphomas (NHL) (n=51) were enrolled in the study. The ASHAP therapy consisted of ADR (40 mg/m2 by continuous infusion (CI) over 96 h), methylprednisolone (500 mg i.v., days 1–5), Ara-C (2 g/m2 as a 2-h infusion on day 5), and CDDP (100 mg/m2 by CI over 96 h). Results: Twenty-five patients (38%) achieved complete remission (CR) and 20 (31%) were taken into partial remission (PR) for an overall response rate of 69%. Thirty-two patients with CR or PR following ASHAP underwent high-dose therapy (HDT) with subsequent hematopoietic stem cell transplantation. After a median follow-up of 52 months, 13 patients are in continuous CR (CCR), the 3-year event-free survival (EFS) was 30% for responders and 21% for all patients. The median overall survival (OS) was 12 months (range 0–70 months), and the OS rate after 3 years was 32%. Unfavorable prognostic factors for EFS and OS by univariate analysis were an elevated value of the serum lactate dehydrogenase and refractory lymphoma. The most frequently observed side effects following ASHAP were leukocytopenia and thrombocytopenia of World Health Organization (WHO) grades III/IV in approximately 80% of all courses. Non-hematological toxicities such as gastrointestinal side effects, infections, mucositis, renal and neurotoxicity occurred more rarely and reached WHO grades III/IV only occasionally. No treatment-related mortality with ASHAP was observed. Conclusions: ASHAP is an effective and moderately toxic salvage therapy for patients with recurrent or refractory HD and NHL. The results in patients responding to ASHAP and afterwards undergoing HDT with stem cell support are comparable with other established protocols and indicate an improvement in survival if HDT is carried out as intensification.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    Langenbeck's archives of surgery 377 (1992), S. 28-33 
    ISSN: 1435-2451
    Keywords: Weichteilsarkome ; Extremitäten und Rumpf ; Klinisches Bild ; Behandlungsmodalitäten ; Prognosefaktoren
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary Between 1970 and 1988 surgery was performed on 124 patients with soft tissue sarcomas of the extremities and trunk in the University Clinics of Hamburg. Liposarcoma, malignant fibrous histiocytoma, fibrosarcoma and malignant schwannoma were the most common histological types. High-grade sarcomas (G3) predominated, with 41 %, while 26% were graded G2 and 33% G1. Resection with wide margins all round was achieved in only 54% of the patients. The quality of the operation proved to be only therapy-related prognostic factor. In addition, tumour grade, size, regional lymph node and distant metastasis and histological type proved to be relevant to the prognosis. With multivariate analysis, distant metastasis, grade, resectability and histological type retained prognostic significance. The efficacy of adjuvant chemo- and radiotherapy was related to the quality of the preceding tumour resection. In case of gross tumour the rate of either partial or complete response was 28% for chemotherapy and 22% for radiotherapy. The mean survival time was 102 months; the 5- and 10-year survival rates were 48% and 37%, respectively.
    Notes: Zusammenfassung In der Chirurgischen Universitätsklinik Hamburg wurden von 1970–1988 124 Patienten mit Weichteilsarkomen der Extremitäten und des Rumpfs operiert. Liposarkome, maligne fibröse Histiozytome, Fibrosarkome und maligne Schwannome waren die häufigsten histologischen Typen. Niedrig differenzierte Sarkome (G3) überwogen mit einem Anteil von 41%, während 26% als G2 und 33% als G1 imponierten. Bei nur 54% der Patienten wurde eine Tumorresektion mit dreidimensional weitem Sicherheitsabstand durchgeführt. Dabei stellte sich die Qualität der Operation (RO/1/2) als einziger im Rahmen der Therapie beeinflu\barer Prognosefaktor heraus. Daneben wurde in der univariaten Analyse das Tumorgrading, die Tumorgröße, die regionalen Lymphknoten- und Fernmetastasen und der histologische Typ als prognostisch relevant ermittelt. In der multivariaten Analyse behielten die Faktoren Fernmetastasen, Grading, Resektabilität und histologischer Typ statistische Signifikanz. Der Erfolg einer adjuvanten Chemo- und Strahlentherapie war erheblich von der Qualität der vorangegangenen Tumorresektion abhängig. Bei klinisch manifestem Tumor wurde mit einer Chemotherapie bei 28% der Fälle eine Voll- oder Teilremission erreicht, mit einer Strahlentherapie bei 22% der Fälle. Die durchschnittliche Überlebenszeit betrug 102 Monate, die 5- und 10-Jahres-Überlebensrate 48% bzw. 37%.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...